AI brief of an SEC Form 8-K · Crown Reserve Acquisition Corp. I (CRAC)

Crown Reserve Acquisition Corp. I amends Carvix merger deal, revises shareholder vote terms

Neutral Impact 3 of 5 m&a Written later

On August 26, 2026, Crown Reserve Acquisition Corp. I (CRAC), its merger subsidiary and Carvix, Inc. signed a First Amendment to their March 30, 2026 Business Combination Agreement. The amendment restates the shareholder vote thresholds for the extraordinary general meeting, makes the advisory organizational documents proposal non-binding and not a closing condition, and sets minimum annualized base salaries for named Carvix executives. The filing states that the amendment does not change any holder's voting rights, and it does not disclose financial results or a deal value.

Key points

  • Amendment dated August 26, 2026 amends the Business Combination Agreement dated March 30, 2026.
  • Domestication and organizational documents proposals require a special resolution of at least two-thirds of Class B ordinary shares; Class A holders have no vote on them.
  • Advisory organizational documents proposals are non-binding and are not a condition to completing the transaction.
  • Base salaries for Carvix executives are set at minimums listed in Annex A, which the filing does not reproduce in its text.

The filing

CompanyCrown Reserve Acquisition Corp. I (CRAC)
Form8-K, current report
Filed with the SECAug 26, 2026, 4:37 PM ET
Accession number0001213900-26-094001

Items reported: 1.01 Material Definitive Agreement

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 26, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.